Cabell Christopher
Insider CIK 1814928 · ARNA EVP, Head of R&D, and CMO · PULM Director · IKT President & Head of R&D · ZURA CMO & Head of R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IKT Inhibikase Therapeutics, I | D To issuer | 2026-02-21 | 2026-02-24 | 338,282 | — | $0 | 676,564 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2026-01-05 | 2026-01-07 | 900,117 | — | $0 | 900,117 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-02-21 | 2025-07-02 | 1,100,705 | — | $0 | 1,100,705 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-02-21 | 2025-02-25 | 1,100,705 | — | $0 | 1,100,705 | SEC↗ |
| ZURA Zura Bio Ltd | A Award | 2023-05-18 | 2023-05-22 | 162,060 | — | $0 | 162,060 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2023-01-26 | 2023-01-30 | 1,700 | — | $0 | 1,700 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2022-01-27 | 2022-01-31 | 22,100 | — | $0 | 22,100 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2021-01-28 | 2021-02-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2020-11-25 | 2020-11-30 | 2,500 | — | $0 | 5,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2020-11-25 | 2020-11-30 | 2,500 | — | $0 | 2,500 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | F Tax w/h | 2020-11-25 | 2020-11-30 | 1,099 | $65.50 | $72.0K | 1,401 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2020-07-15 | 2020-07-17 | 13,000 | — | $0 | 47,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | S Sale | 2020-07-15 | 2020-07-17 | 13,000 | $68.00 | $884.0K | 0 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2020-07-15 | 2020-07-17 | 13,000 | $26.28 | $341.6K | 13,000 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2020-06-23 | 2020-06-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2020-06-12 | 2020-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |